Allison Baker

Allison Baker is a scientist, in RNA technology at Verve Therapeutics, with expertise in RNA biology. Prior to joining Verve, she received her Ph.D. in Biological and Biomedical Sciences from Harvard Medical School, where she explored oncogenic mechanisms of the RNA editing enzyme ADAR1 in triple-negative breast cancer. She received her B.S. in Biology from the University of North Carolina at Chapel Hill.